RHY 4.76% 6.0¢ rhythm biosciences limited

News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods, page-55

  1. 550 Posts.
    lightbulb Created with Sketch. 85
    Nice little bounce today on low volumes.
    For those that haven't seen there is relatively new analyst coverage (MST) on Rhythm's website.
    The following milestones are included. Nothing of surprise for the hardened followers here but a good reminder that there are numerous inflection points in the coming months (or perhaps days/weeks):

    Potential Milestones
    • H2CY22 First revenues/income
    • H2CY22 TGA approval/ Australian Register of Therapeutic Goods (ARTG) Listing
    • H2CY22 Commercial Partnering Deals
    • H2CY22 Additional Regulatory Submissions
    Last edited by clio: 13/07/22
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.